• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用伊匹单抗进行CTLA-4阻断治疗可使一名黑色素瘤发生中枢神经系统转移的女性患者获得显著的临床益处。

CTLA-4 blockade with ipilimumab induces significant clinical benefit in a female with melanoma metastases to the CNS.

作者信息

Hodi F Stephen, Oble Darryl A, Drappatz Jan, Velazquez Elsa F, Ramaiya Nikhil, Ramakrishna Naren, Day Arthur L, Kruse Andrea, Mac Rae Suzanne, Hoos Axel, Mihm Martin

机构信息

Melanoma Program, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA.

出版信息

Nat Clin Pract Oncol. 2008 Sep;5(9):557-61. doi: 10.1038/ncponc1183. Epub 2008 Jul 29.

DOI:10.1038/ncponc1183
PMID:18665147
Abstract

BACKGROUND

A 63-year-old female presented to her primary physician with numbness and weakness in her left leg, which progressed over several days to involve her entire lower extremities. MRI of the spine and brain revealed multiple metastases. The patient received ipilimumab and after 3 months experienced intermittent confusion and focal seizures.

INVESTIGATIONS

Electroencephalogram and MRI scans of the spine and brain, followed by surgical removal of a left frontal cortical brain metastasis and subsequent histological and pathological analyses.

DIAGNOSIS

Metastatic melanoma from an unknown primary tumor.

MANAGEMENT

The patient was treated with ipilimumab on a compassionate-use program and dexamethasone, celecoxib, and levetiracetam to treat the symptoms and seizures. Postoperative stereotactic radiosurgery was initiated.

摘要

背景

一名63岁女性因左腿麻木和无力就诊于她的初级保健医生,症状在数天内进展至累及整个下肢。脊柱和脑部的MRI显示多处转移。患者接受了伊匹单抗治疗,3个月后出现间歇性意识模糊和局灶性癫痫发作。

检查

进行脑电图以及脊柱和脑部的MRI扫描,随后手术切除左额叶皮质脑转移瘤,并进行后续的组织学和病理学分析。

诊断

原发肿瘤不明的转移性黑色素瘤。

治疗

患者在同情用药计划下接受伊匹单抗治疗,并使用地塞米松、塞来昔布和左乙拉西坦治疗症状和癫痫发作。术后开始进行立体定向放射外科治疗。

相似文献

1
CTLA-4 blockade with ipilimumab induces significant clinical benefit in a female with melanoma metastases to the CNS.使用伊匹单抗进行CTLA-4阻断治疗可使一名黑色素瘤发生中枢神经系统转移的女性患者获得显著的临床益处。
Nat Clin Pract Oncol. 2008 Sep;5(9):557-61. doi: 10.1038/ncponc1183. Epub 2008 Jul 29.
2
Ipilimumab in melanoma with limited brain metastases treated with stereotactic radiosurgery.立体定向放疗治疗脑转移局限的黑色素瘤患者中使用伊匹单抗。
Melanoma Res. 2013 Jun;23(3):191-5. doi: 10.1097/CMR.0b013e32835f3d90.
3
Swinging for the Fences: Long-Term Survival With Ipilimumab in Metastatic Melanoma.挥棒击球:依匹单抗治疗转移性黑色素瘤的长期生存。
J Clin Oncol. 2015 Jun 10;33(17):1873-7. doi: 10.1200/JCO.2014.60.1807. Epub 2015 May 11.
4
Ipilimumab and craniotomy in patients with melanoma and brain metastases: a case series.伊匹单抗与黑色素瘤脑转移患者的开颅手术:病例系列
Neurosurg Focus. 2015 Mar;38(3):E5. doi: 10.3171/2014.12.FOCUS14698.
5
Long-term survival in metastatic malignant melanoma: ipilimumab followed by vemurafenib in a patient with brain metastasis.转移性恶性黑色素瘤患者的长期生存:1例脑转移患者接受伊匹单抗后序贯维莫非尼治疗
Intern Med. 2012;51(19):2819-23. doi: 10.2169/internalmedicine.51.7675. Epub 2012 Oct 1.
6
Potential role for LINAC-based stereotactic radiosurgery for the treatment of 5 or more radioresistant melanoma brain metastases.基于直线加速器的立体定向放射外科治疗5个或更多放射性抵抗性黑色素瘤脑转移瘤的潜在作用。
J Neurosurg. 2015 Nov;123(5):1261-7. doi: 10.3171/2014.12.JNS141919. Epub 2015 Jul 3.
7
Biochemotherapy of metastatic melanoma in patients with or without recently diagnosed brain metastases.有或无近期诊断出脑转移的转移性黑色素瘤患者的生物化疗
Cancer. 2007 Sep 15;110(6):1329-37. doi: 10.1002/cncr.22905.
8
Ipilimumab and radiation therapy for melanoma brain metastases.伊匹单抗联合放射治疗黑色素瘤脑转移。
Cancer Med. 2013 Dec;2(6):899-906. doi: 10.1002/cam4.140. Epub 2013 Oct 10.
9
Survival and prognostic factors in patients with brain metastases from malignant melanoma.恶性黑色素瘤脑转移患者的生存及预后因素
Onkologie. 2004 Apr;27(2):145-9. doi: 10.1159/000076903.
10
Treatment of melanoma metastases in the brain.脑转移性黑色素瘤的治疗
Semin Surg Oncol. 1996 Nov-Dec;12(6):429-35. doi: 10.1002/(SICI)1098-2388(199611/12)12:6<429::AID-SSU8>3.0.CO;2-C.

引用本文的文献

1
Programmed Death-1 Ligand 1 Domain Organization, Signaling Motifs, and Interactors in Cancer Immunotherapy.癌症免疫治疗中的程序性死亡-1配体1结构域组织、信号基序及相互作用分子
Cancers (Basel). 2025 May 12;17(10):1635. doi: 10.3390/cancers17101635.
2
Abscopal Effects and Immunomodulation in Skin Cancer Therapy.皮肤癌治疗中的远隔效应与免疫调节
Am J Clin Dermatol. 2025 Apr 3. doi: 10.1007/s40257-025-00943-x.
3
Granzyme-targeting quenched activity-based probes for assessing tumor response to immunotherapy.用于评估肿瘤对免疫疗法反应的靶向颗粒酶的猝灭型基于活性的探针。
bioRxiv. 2025 Mar 15:2025.03.13.643086. doi: 10.1101/2025.03.13.643086.
4
Timing of brain metastases in relation to outcome during first-line ipilimumab plus nivolumab therapy for metastatic melanoma in a community oncology practice.社区肿瘤实践中一线使用伊匹木单抗加纳武单抗治疗转移性黑色素瘤时脑转移发生时间与预后的关系
J Neurooncol. 2025 May;172(3):645-653. doi: 10.1007/s11060-025-04951-z. Epub 2025 Feb 11.
5
The Optimal Radiotherapy Strategy for Patients With Small Cell Lung Cancer and Brain Metastasis: A Retrospective Analysis.小细胞肺癌伴脑转移患者的最佳放疗策略:一项回顾性分析。
CNS Neurosci Ther. 2024 Nov;30(11):e70102. doi: 10.1111/cns.70102.
6
Breaking the 'don't eat me' signal: in silico design of CD47-directed peptides for cancer immunotherapy.打破“别吃我”信号:用于癌症免疫治疗的CD47导向肽的计算机辅助设计
Mol Divers. 2024 Oct;28(5):3067-3083. doi: 10.1007/s11030-023-10732-5. Epub 2023 Sep 28.
7
Systemic CD4 Immunity and PD-L1/PD-1 Blockade Immunotherapy.系统性 CD4 免疫与 PD-L1/PD-1 阻断免疫疗法。
Int J Mol Sci. 2022 Oct 31;23(21):13241. doi: 10.3390/ijms232113241.
8
Case report: Significant benefits of tislelizumab combined with anlotinib in first-line treatment of metastatic renal pelvic urothelial carcinoma with sarcomatoid carcinoma differentiation.病例报告:替雷利珠单抗联合安罗替尼一线治疗伴肉瘤样癌分化的转移性肾盂尿路上皮癌的显著疗效
Front Oncol. 2022 Oct 18;12:969106. doi: 10.3389/fonc.2022.969106. eCollection 2022.
9
Analysis of Spatial Heterogeneity of Responses in Metastatic Sites in Renal Cell Carcinoma Patients Treated with Nivolumab.分析纳武利尤单抗治疗的肾细胞癌患者转移灶反应的空间异质性。
Tomography. 2022 May 20;8(3):1363-1373. doi: 10.3390/tomography8030110.
10
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of lung cancer and mesothelioma.癌症免疫治疗学会(SITC)临床实践指南:免疫治疗肺癌和间皮瘤。
J Immunother Cancer. 2022 May;10(5). doi: 10.1136/jitc-2021-003956.